Literature DB >> 9780261

Vaccination of gnotobiotic piglets against Helicobacter pylori.

K A Eaton1, S S Ringler, S Krakowka.   

Abstract

To determine the effect of oral adjuvant-assisted and parenteral vaccination, germ-free piglets were vaccinated orally with and without labile toxin adjuvant or parenterally and challenged with viable Helicobacter pylori. All prechallenge vaccination regimens induced anti-H. pylori antibodies and suppressed bacterial colonization, but no vaccination regime completely prevented infection. Parenteral vaccination given after infection had no effect on bacterial colonization. Lymphocytic gastritis was present in all piglets challenged with live bacteria regardless of vaccination status. Neutrophilic gastritis was present in vaccinated challenged piglets but not in infected, unvaccinated piglets. Gastritis was not present in uninfected control piglets regardless of vaccination status. In gnotobiotic piglets, vaccination suppresses but does not prevent infection by H. pylori, and parenteral vaccination does not cure infected piglets. Vaccination does not ameliorate gastritis due to H. pylori in piglets but does induce neutrophilic gastric inflammation in some infected piglets.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780261     DOI: 10.1086/314463

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice.

Authors:  K A Eaton; M E Mefford
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models.

Authors:  K A Eaton; D Kersulyte; M Mefford; S J Danon; S Krakowka; D E Berg
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 3.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

4.  A Gnotobiotic Pig Model for Determining Human Norovirus Inactivation by High-Pressure Processing.

Authors:  Fangfei Lou; Mu Ye; Yuanmei Ma; Xinhui Li; Erin DiCaprio; Haiqiang Chen; Steven Krakowka; John Hughes; David Kingsley; Jianrong Li
Journal:  Appl Environ Microbiol       Date:  2015-07-17       Impact factor: 4.792

Review 5.  Vaccinating against Helicobacter pylori infection.

Authors:  Steven J Czinn; Thomas Blanchard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

6.  Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta).

Authors:  J V Solnick; D R Canfield; L M Hansen; S Z Torabian
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 7.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  Effect of bacterial flora on postimmunization gastritis following oral vaccination of mice with Helicobacter pylori heat shock protein 60.

Authors:  Hiroyuki Yamaguchi; Takako Osaki; Haruhiko Taguchi; Noriko Sato; Atushi Toyoda; Motomichi Takahashi; Masanori Kai; Noboru Nakata; Akio Komatsu; Yutaka Atomi; Shigeru Kamiya
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

9.  Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Mireia Pedragosa; Salvador Vento; Raquel Hontecillas
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

10.  Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.

Authors:  R Weltzin; B Guy; W D Thomas; P J Giannasca; T P Monath
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.